Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (468)

Latest Posts

About This Stock More About This Stock
Gilead’s Remdesivir Brought In $873 Million During The Third Quarter
Video By: CNBC
Wednesday, October 28, 2020 4:51 PM EST
Gilead reports quarterly earnings results.
In this video: GILD
Watch
Healthcare To Post Solid Q3 Earnings Growth: ETFs In Focus
Article By: Sweta Killa
Sunday, October 25, 2020 5:47 PM EST
Major pharma companies are due to report earnings in the coming weeks and the price movement of the big healthcare ETFs is dependent upon the results.
In this article: MRK, AMGN, ABBV, GILD, BMY, PFE, IYH, VHT, XLV, FHLC Also: JNJ, LLY
Read
US, UK Market Review And News; What To Watch
Article By: Adam Vettese
Friday, October 23, 2020 8:36 AM EST
Uber and Lyft will be stocks to watch when the market opens. Both companies gained about 4% Thursday, but late in the evening a ruling came through against them in their legal battle over classifying drivers as contractors rather than employees.
In this article: BITCOMP, AXP, ITW, ALGN, GILD Also: INTC, LYFT, UBER, QQQ, DIA, SPY
Read
October 2020 Stock Considerations
Article By: Keith Park
Sunday, October 4, 2020 11:30 PM EST
New month, new stock considerations. Here's my short list for October.
In this article: MO, SO, T, AVGO, GILD
Read
Oracle Wins TikTok Bid, Nvidia Buys Arm For $40bn
Article By: Adam Vettese
Monday, September 14, 2020 6:00 AM EST
The weekend was packed with M&A news, with three deals all likely to be well north of $10bn apiece reported. First up, Oracle has reportedly won the bidding to buy TikTok’s US operations, with the Microsoft-Walmart joint offer being rejected.
In this article: APA, CVX, IAG, LEN, OXY, WMT, XOM, AIVAF, GLCNF, IMMU, AAPL, ARMH, GILD, INTC, MSFT, NVDA, ORCL, DIA, FXB, SPY, COMP, SPX, BITCOMP, NGLOY, ETH-X, JDDSF, RTPPF, SFTBY
Read

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments